| 注册
首页|期刊导航|新医学|高尿酸血症及痛风达标治疗的必由之路——健康管理

高尿酸血症及痛风达标治疗的必由之路——健康管理

古洁若 招淑珠

新医学2017,Vol.48Issue(6):365-368,4.
新医学2017,Vol.48Issue(6):365-368,4.DOI:10.3969/j.issn.0253-9802.2017.06.001

高尿酸血症及痛风达标治疗的必由之路——健康管理

Necessity of health management in the treat-to-target therapy of hyperuricemia and gout

古洁若 1招淑珠1

作者信息

  • 1. 510630 广州,中山大学附属第三医院风湿免疫科
  • 折叠

摘要

Abstract

In recent years,the prevalence of hyperuricemia and gout is unceasingly elevating and predisposes to younger age in China.The goal of hyperuricemia and gout therapy is to maintain the serum level of uric acid lower than 300 μmol/L for premenopausal women or 360 μmol/L for men and postmenopausal women.Previous investigations have demonstrated that proper guidance on life style and uric acid level-lowering drugs contribute to reduce the serum level of uric acid.Nevertheless,the treat-to-target rate of serum level of uric acid is extremely low,and the understanding rate of the importance of individualized therapy and monitoring of serum uric acid is equally low in China.Enhancing the treat-to-target rate of hyperuricemia is a crucial step to reduce the risk of hyperuricemia-and gout-related complications and prolong the survival of patients.Health management plays a pivotal role in the treat-to-target therapy of hyperuricemia and gout,which deserves widespread promotion and application.

关键词

高尿酸血症/痛风/健康管理/达标治疗

Key words

Hyperuricemia/Gout/Health management/Treat-to-target therapy

引用本文复制引用

古洁若,招淑珠..高尿酸血症及痛风达标治疗的必由之路——健康管理[J].新医学,2017,48(6):365-368,4.

新医学

OACSTPCD

0253-9802

访问量7
|
下载量0
段落导航相关论文